RxDoctor Payments Data

Robert Richard

Hematology & Oncology · Seattle, WANPI 1720164478

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 1 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Every reported general payment came from a single manufacturer, Novartis. That places this record below the midpoint for hematology & oncology clinicians in WA, where the typical reported total is $899.

$19in general payments, 2019–2025

Across 1 payment — averaging $18.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$19
$791,072in research payments, 2019–2025

Across 29 payments — averaging $27,278 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Novartis$655K
  • AbbVie$88K
  • E.r. Squibb & Sons, L.L.C.$37K
  • Incyte Corporation$11K

What the payments were for

  • Food & beverage$19100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novartis1$19

How this compares

$19 in reported general payments places this provider in the 0th percentile of 349 hematology & oncology providers in Washington.

See all hematology & oncology providers in Washington

Other hematology & oncology in Seattle

See the full list for Washington

Where these figures come from

Is this you, or does something look wrong? →